There will be a joint FDA/International Myeloma Society workshop on drug development in myeloma. Nov 8-9.
Myeloma has been at the forefront of advances in cancer therapy. Register if interested. Over 1000 have already registered. @US_FDA @Myeloma_Society fda.gov/drugs/news-eve…
Myeloma has been at the forefront of advances in cancer therapy. Register if interested. Over 1000 have already registered. @US_FDA @Myeloma_Society fda.gov/drugs/news-eve…
If you have interest in how we wrestle with competing issues, trial designs, endpoints, and the type of difficult decisions that are made in drug development balancing the needs of the patient, efficacy, safety, etc this workshop will be educational.
The topics discussed will be relevant to all cancers and so those who are in other related fields of oncology will also find the workshop helpful.
Top FDA leaders, and a number of myeloma experts are presenting at the meeting.
#NikhilMunshi, #JesusSanMiguel, #PhilippeMoreau, @myelomaMD @SagarLonialMD @szusmani @NoopurRajeMD @AjayNookaMD @IreneGhobrial @mvmateos @Myeloma_Doc and many more.
#NikhilMunshi, #JesusSanMiguel, #PhilippeMoreau, @myelomaMD @SagarLonialMD @szusmani @NoopurRajeMD @AjayNookaMD @IreneGhobrial @mvmateos @Myeloma_Doc and many more.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
